These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Comprehensive meta-analysis reveals distinct gene expression signatures of MASLD progression. Piras IS; DiStefano JK Life Sci Alliance; 2024 Jun; 7(6):. PubMed ID: 38565287 [TBL] [Abstract][Full Text] [Related]
33. Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease. Semmler G; Balcar L; Wernly S; Völkerer A; Semmler L; Hauptmann L; Wernly B; Aigner E; Niederseer D; Datz C Front Endocrinol (Lausanne); 2023; 14():1244405. PubMed ID: 37842290 [TBL] [Abstract][Full Text] [Related]
34. Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma. Ha S; Wong VW; Zhang X; Yu J Gut; 2024 Jun; ():. PubMed ID: 38950910 [TBL] [Abstract][Full Text] [Related]
35. A natural language processing algorithm accurately classifies steatotic liver disease pathology to estimate the risk of cirrhosis. Sherman MS; Challa PK; Przybyszewski EM; Wilechansky RM; Uche-Anya EN; Ott AT; McGoldrick J; Goessling W; Khalili H; Simon TG Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38551386 [TBL] [Abstract][Full Text] [Related]
36. Ablation of IFNγ in myeloid cells suppresses liver inflammation and fibrogenesis in mice with hepatic small heterodimer partner (SHP) deletion. Zhu L; Litts B; Wang Y; Rein JA; Atzrodt CL; Chinnarasu S; An J; Thorson AS; Xu Y; Stafford JM Mol Metab; 2024 May; 83():101932. PubMed ID: 38589002 [TBL] [Abstract][Full Text] [Related]
37. Phenotypes of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma. Rivera-Esteban J; Muñoz-Martínez S; Higuera M; Sena E; Bermúdez-Ramos M; Bañares J; Martínez-Gomez M; Cusidó MS; Jiménez-Masip A; Francque SM; Tacke F; Minguez B; Pericàs JM Clin Gastroenterol Hepatol; 2024 Apr; ():. PubMed ID: 38604295 [TBL] [Abstract][Full Text] [Related]
38. Hepatitis regulation by the inflammasome signaling pathway. Negash AA; Gale M Immunol Rev; 2015 May; 265(1):143-55. PubMed ID: 25879290 [TBL] [Abstract][Full Text] [Related]
39. The double roles of T cell-mediated immune response in the progression of MASLD. Li Z; Wang S; Xu Q; Su X; Wang Y; Wang L; Zhang Y Biomed Pharmacother; 2024 Apr; 173():116333. PubMed ID: 38479177 [TBL] [Abstract][Full Text] [Related]
40. Apelin and the gut microbiome: Potential interaction in human MASLD. Effenberger M; Grander C; Hausmann B; Enrich B; Pjevac P; Zoller H; Tilg H Dig Liver Dis; 2024 Jun; 56(6):932-940. PubMed ID: 38087672 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]